Literature DB >> 26075647

Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?

David C Perlman1, Don C Des Jarlais, Jonathan Feelemyer.   

Abstract

HIV and hepatitis C virus (HCV) infection are readily transmitted among persons who inject drugs. The HIV and HCV epidemics have expanded rapidly, becoming global health issues. Combined prevention has been implemented to reduce injection and sexual transmission of HIV and HCV among persons who inject drugs. Reductions in risky injection and sexual behavior have led to dramatic reductions in HIV in many countries. Whether comparable reductions in HCV transmission can be achieved has yet to be determined. Eliminating HIV and HCV among persons who inject drugs will require considerable resources and commitment, particularly in low and middle income countries.

Entities:  

Keywords:  HIV; combined prevention; drug injection; hepatitis C virus; persons who inject drugs

Mesh:

Year:  2015        PMID: 26075647      PMCID: PMC4550554          DOI: 10.1080/10550887.2015.1059111

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  59 in total

1.  A certain fate: spread of HIV among young injecting drug users in Manipur, north-east India.

Authors:  A D Eicher; N Crofts; S Benjamin; P Deutschmann; A J Rodger
Journal:  AIDS Care       Date:  2000-08

2.  Harm reduction and control of HIV in IDUs in France.

Authors:  M Patrizia Carrieri; Bruno Spire
Journal:  Lancet       Date:  2008-08-09       Impact factor: 79.321

Review 3.  HIV prevention for injecting drug users: the first 25 years and counting.

Authors:  Don C Des Jarlais; Salaam Semaan
Journal:  Psychosom Med       Date:  2008-06-02       Impact factor: 4.312

Review 4.  HIV infection among intravenous drug users: epidemiology and risk reduction.

Authors:  D C Des Jarlais; S R Friedman
Journal:  AIDS       Date:  1987-07       Impact factor: 4.177

Review 5.  Current progress in development of hepatitis C virus vaccines.

Authors:  T Jake Liang
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 6.  Can hepatitis C virus infection be eradicated in people who inject drugs?

Authors:  Jason Grebely; Gregory J Dore
Journal:  Antiviral Res       Date:  2014-01-24       Impact factor: 5.970

7.  "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Holly Hagan; Judith Milliken; Naomi Braine; Stanley Yancovitz; Donna Mildvan; David C Perlman; Carey Maslow; Samuel R Friedman
Journal:  J Acquir Immune Defic Syndr       Date:  2004-02-01       Impact factor: 3.731

8.  Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.

Authors:  Mark S Sulkowski; Susanna Naggie; Jacob Lalezari; Walford Jeffrey Fessel; Karam Mounzer; Margaret Shuhart; Anne F Luetkemeyer; David Asmuth; Anuj Gaggar; Liyun Ni; Evguenia Svarovskaia; Diana M Brainard; William T Symonds; G Mani Subramanian; John G McHutchison; Maribel Rodriguez-Torres; Douglas Dieterich
Journal:  JAMA       Date:  2014 Jul 23-30       Impact factor: 56.272

9.  Causes of death in patients with hepatitis B: a natural history cohort study in the United States.

Authors:  Jean-Luc Szpakowski; Lue-Yen Tucker
Journal:  Hepatology       Date:  2012-12-12       Impact factor: 17.425

10.  Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections.

Authors:  Amy Lansky; Teresa Finlayson; Christopher Johnson; Deborah Holtzman; Cyprian Wejnert; Andrew Mitsch; Deborah Gust; Robert Chen; Yuko Mizuno; Nicole Crepaz
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

View more
  11 in total

1.  Trends in HIV Infection Among Persons Who Inject Drugs: United States and Puerto Rico, 2008-2013.

Authors:  Andrew John Mitsch; H Irene Hall; Aruna Surendera Babu
Journal:  Am J Public Health       Date:  2016-09-15       Impact factor: 9.308

2.  Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation.

Authors:  Ashly E Jordan; David C Perlman; Charles M Cleland; Katarzyna Wyka; Bruce R Schackman; Denis Nash
Journal:  J Clin Virol       Date:  2020-01-27       Impact factor: 3.168

3.  Utilizing social media to explore overdose and HIV/HCV risk behaviors among current opioid misusers.

Authors:  Patricia Cavazos-Rehg; Richard Grucza; Melissa J Krauss; Austin Smarsh; Nnenna Anako; Erin Kasson; Nina Kaiser; Samantha Sansone; Rachel Winograd; Laura J Bierut
Journal:  Drug Alcohol Depend       Date:  2019-10-28       Impact factor: 4.492

Review 4.  The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions.

Authors:  David C Perlman; Ashly E Jordan
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

5.  Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for "Ending the Epidemic".

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Jonathan Feelemyer; Holly Hagan; Hannah L F Cooper; Aimee N C Campbell; Susan Tross; David C Perlman
Journal:  AIDS Behav       Date:  2016-02

6.  Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.

Authors:  Ashly E Jordan; Charles M Cleland; Katarzyna Wyka; Bruce R Schackman; David C Perlman; Denis Nash
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

Review 7.  Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis.

Authors:  Ashly E Jordan; David C Perlman; Joshua Neurer; Daniel J Smith; Don C Des Jarlais; Holly Hagan
Journal:  Int J STD AIDS       Date:  2016-07-10       Impact factor: 1.359

Review 8.  Conceptualizing Care Continua: Lessons from HIV, Hepatitis C Virus, Tuberculosis and Implications for the Development of Improved Care and Prevention Continua.

Authors:  David C Perlman; Ashly E Jordan; Denis Nash
Journal:  Front Public Health       Date:  2017-01-10

9.  Feasibility and Acceptability of an mHealth-Based Approach as an HIV Prevention Strategy Among People Who Use Drugs on Pre-Exposure Prophylaxis.

Authors:  Roman Shrestha; Frederick L Altice; Elizabeth DiDomizio; Brian Sibilio; Yerina S Ranjit; Michael M Copenhaver
Journal:  Patient Prefer Adherence       Date:  2020-01-16       Impact factor: 2.711

Review 10.  Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?

Authors:  Katherine M Rich; Joshua Bia; Frederick L Altice; Judith Feinberg
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.